Russia - Pharmaceutical partnership
A manufacturer of antibiotics and antituberculous drugs is looking for a partner to support its R&D project.
The R&D department of a Russian pharma company is close to going through pre-clinical studies with a new drug dosage form of second-line TB medicine.
The advantages include 100% bioavailability, higher efficiency and lower toxicity which have been confirmed during pre-clinical studies.
The 'First-in-man' study will start in 2018. Intellectual property is protected as well.
The company is interested in working with a partner company which will be able to support this project and be responsible for all activities in other countries.
Submit your proposal to the Department for International Trade team in Russia.
All proposals will be reviewed and you will be notified of any potential next steps. You can only submit a proposal if you are a UK registered proposal.
The deadline to apply for this opportunity has passed.
Visit the opportunities page to find another.